Section 151.361 — Manufacturer Disclosure.
151.361 MANUFACTURER DISCLOSURE. Subdivision 1. After January 1, 1976. The manufacturer, packager, or distributor of any human use legend drug sold, delivered, or offered for sale in the state of Minnesota after January 1, 1976 must have printed on the label on the immediate container of the drug the name and address of the manufacturer […]
Section 151.37 — Legend Drugs; Who May Prescribe, Possess.
151.37 LEGEND DRUGS; WHO MAY PRESCRIBE, POSSESS. Subdivision 1. Prohibition. Except as otherwise provided in this chapter, it shall be unlawful for any person to have in possession, or to sell, give away, barter, exchange, or distribute a legend drug. Subd. 2. Prescribing and filing. (a) A licensed practitioner in the course of professional practice […]
Section 151.375 — Investigational Drug Use.
151.375 INVESTIGATIONAL DRUG USE. Subdivision 1. Title; citation. This section may be cited as the “Right to Try Act.” Subd. 2. Definitions. (a) For the purposes of this section, the following terms have the meanings given them. (b) “Eligible patient” means a patient who meets the requirements in subdivision 3. (c) “Investigational drug, biological product, […]
Section 151.302 — Immunity.
151.302 IMMUNITY. Members of the board and persons employed by the board or engaged in maintaining records and making reports regarding adverse health care events are immune from civil liability and criminal prosecution for any actions, transactions, or publications in the execution of or relating to their duties under section 151.301. History: 2004 c 186 […]
Section 151.32 — Citation.
151.32 CITATION. The title of sections 151.01 to 151.58 shall be the Pharmacy Practice and Wholesale Distribution Act. History: (5808-35) 1937 c 354 s 35; 1988 c 550 s 17; 2017 c 40 art 1 s 40; 1Sp2019 c 9 art 10 s 40
Section 151.22 — Liability For Quality Of Drugs.
151.22 LIABILITY FOR QUALITY OF DRUGS. Every pharmacist in charge or proprietor of a pharmacy shall be responsible for the quality of all drugs, medicines, chemicals, and poisons procured for use and sold therein, except proprietary medicines or other articles sold in the original package of the manufacturer. History: (5808-23) 1937 c 354 s 23; […]
Section 151.23 — Poisons Must Be Labeled.
151.23 POISONS MUST BE LABELED. It shall be unlawful for any person to sell at retail any poison without affixing to the package or receptacle containing the same a label conspicuously bearing the word “poison,” and the name and the business address of the seller, and being satisfied that such poison is to be legitimately […]
Section 151.24 — Sale Of Poisons Must Be Recorded.
151.24 SALE OF POISONS MUST BE RECORDED. It shall be unlawful: (1) for any person, either acting independently or while in the employ of another, to sell or give away any poison, as designated by the board, without first recording in a book to be kept for that purpose with an indelible pencil or ink […]
Section 151.252 — Licensing Of Drug Manufacturers; Fees; Prohibitions.
151.252 LICENSING OF DRUG MANUFACTURERS; FEES; PROHIBITIONS. Subdivision 1. Requirements. (a) No person shall act as a drug manufacturer without first obtaining a license from the board and paying any applicable fee specified in section 151.065. (b) In addition to the license required under paragraph (a), each manufacturer required to pay the registration fee under […]
Section 151.253 — Compounding.
151.253 COMPOUNDING. Subdivision 1. Exemption from manufacturing licensure requirement. Section 151.252 shall not apply to: (1) a practitioner engaged in extemporaneous compounding, anticipatory compounding, or compounding not done pursuant to a prescription drug order when permitted by this chapter or the rules of the board; and (2) a pharmacy in which a pharmacist is engaged […]